Highbridge Capital Management’s Dentsply Sirona XRAY Stock Holding History

Highbridge Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-186,849	Closed	-$8.18M	–	906
2018 Q2	$8.18M	Sell	186,849 -51,974	-22%	-$2.44M	0.16%	170
2018 Q1	$12M	Buy	+238,823	New	+$14.1M	0.19%	120
2017 Q1	–	Sell	-35,757	Closed	-$2.06M	–	1760
2016 Q4	$2.06M	Sell	35,757 -29,477	-45%	-$1.74M	0.04%	377
2016 Q3	$3.88M	Buy	65,234 +54,411	+503%	+$3.34M	0.06%	314
2016 Q2	$671K	Buy	+10,823	New	+$666K	0.01%	744
2015 Q4	–	Sell	-18,138	Closed	-$917K	–	1855
2015 Q3	$917K	Buy	+18,138	New	+$966K	0.01%	806
2015 Q2	–	Sell	-58,009	Closed	-$3M	–	1711
2015 Q1	$2.95M	Buy	+58,009	New	+$2.99M	0.04%	442
2014 Q2	–	Sell	-12,444	Closed	-$573K	–	1329
2014 Q1	$573K	Buy	+12,444	New	+$576K	0.01%	673

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Highbridge Capital Management's XRAY Position: Q3 2018 in Review

Highbridge Capital Management sold out of Dentsply Sirona (XRAY) in Q3 2018, closing a stake of 186,849 shares — an estimated $8.18M sold.

Highbridge Capital Management first reported a position in XRAY in Q1 2014 and held it in 8 quarters. The position peaked at $12M in Q1 2018. 522 funds tracked by Wall St. Rank hold XRAY as of Q3 2018.

Highbridge Capital Management reported no remaining Dentsply Sirona position as of Q3 2018 after selling out during the quarter.
Highbridge Capital Management sold 186,849 Dentsply Sirona shares in Q3 2018, an estimated $8.18M.
Highbridge Capital Management first reported a position in Dentsply Sirona in Q1 2014 and held it in 8 quarters.
Highbridge Capital Management's Dentsply Sirona position peaked at $12M in Q1 2018.
522 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.